# DAMP-Mediated Innate Immune Failure and Pneumonia After Trauma - the Harvard-Longwood (HALO) Campus Area Consortium

> **NCT03993002** · NA · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Respiratory Failure

## Interventions

- **OTHER:** Normoxia with Normocarbia
- **OTHER:** Normoxia with Hypercarbia
- **OTHER:** Hyperoxia with Normocarbia
- **OTHER:** Hyperoxia with Hypercarbia

## Key facts

- **NCT ID:** NCT03993002
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-15
- **Primary completion:** 2020-03-15
- **Final completion:** 2021-10-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Enrollment pause due to COVID-19 exceeded funding period; This is not a suspension of IRB approval.
- **Last updated:** 2022-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03993002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03993002, "DAMP-Mediated Innate Immune Failure and Pneumonia After Trauma - the Harvard-Longwood (HALO) Campus Area Consortium". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03993002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*